US Stock MarketDetailed Quotes

OCUL Ocular Therapeutix

Watchlist
  • 8.690
  • -0.200-2.25%
Close Dec 13 16:00 ET
  • 8.690
  • 0.0000.00%
Post 16:20 ET
1.37BMarket Cap-7.30P/E (TTM)

Ocular Therapeutix Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-372.83%-36.56M
-23.55%-24.8M
-69.66%-33.89M
-17.84%-70.23M
-32.41%-22.45M
41.29%-7.73M
-84.58%-20.08M
-7.38%-19.97M
9.07%-59.6M
-11.91%-16.96M
Net income from continuing operations
-6,972.29%-36.49M
-111.67%-43.78M
-113.89%-64.85M
-13.65%-80.74M
-88.01%-29.22M
97.87%-516K
-10.21%-20.68M
-141.73%-30.32M
-984.05%-71.04M
-303.69%-15.54M
Operating gains losses
66.16%-7.08M
367.64%3.03M
404.45%33.1M
34.96%-9M
223.59%6.48M
-1,947.35%-20.91M
59.21%-1.13M
194.34%6.56M
82.28%-13.84M
66.97%-5.24M
Depreciation and amortization
7.75%959K
46.63%956K
90.48%920K
41.44%2.98M
95.11%958K
74.85%890K
18.12%652K
-13.29%483K
-12.89%2.11M
-13.86%491K
Other non cash items
-70.03%621K
-54.59%569K
60.26%1.97M
25.82%6.11M
25.55%1.55M
69.14%2.07M
3.98%1.25M
3.54%1.23M
4.86%4.85M
4.12%1.24M
Change In working capital
-119.46%-1.21M
168.34%3.13M
-420.28%-13.01M
-649.37%-7.41M
-206.93%-6.55M
59.01%6.22M
-199.03%-4.58M
50.53%-2.5M
146.50%1.35M
-107.28%-2.14M
-Change in receivables
-100.08%-3K
40.40%-3.69M
-282.59%-367K
-2,454.74%-4.85M
-70.06%-2.59M
447.06%3.72M
-326.97%-6.19M
109.70%201K
97.86%-190K
3.79%-1.52M
-Change in inventory
367.92%142K
-56.45%27K
7.88%-269K
54.28%-331K
88.81%-48K
-17.78%-53K
143.66%62K
-170.37%-292K
-1,377.55%-724K
-1,432.14%-429K
-Change in prepaid assets
-2,515.24%-7.04M
913.07%1.55M
117.83%128K
-620.89%-3.77M
-312.96%-2.93M
-155.69%-269K
-82.39%153K
-986.42%-718K
815.84%723K
18.76%-710K
-Change in payables and accrued expense
107.45%5.9M
671.63%5.44M
-669.68%-12.34M
32.55%1.36M
-172.39%-590K
-4.02%2.84M
-49.86%705K
61.48%-1.6M
-81.44%1.02M
47.11%815K
-Change in other current assets
-19.01%311K
-85.52%54K
-0.96%413K
149.45%1.57M
--396K
--384K
--373K
497.14%417K
-424.97%-3.18M
----
-Change in other current liabilities
-63.74%-447K
63.58%-193K
-49.28%-515K
-166.43%-1.81M
---665K
---273K
---530K
---345K
300.96%2.73M
----
-Change in other working capital
39.69%-79K
-107.36%-62K
63.13%-59K
-55.66%427K
-178.48%-124K
22.02%-131K
349.11%842K
-112.20%-160K
-3.70%963K
--158K
Cash from discontinued investing activities
Operating cash flow
-372.83%-36.56M
-23.55%-24.8M
-69.66%-33.89M
-17.84%-70.23M
-32.41%-22.45M
41.29%-7.73M
-84.58%-20.08M
-7.38%-19.97M
9.07%-59.6M
-11.91%-16.96M
Investing cash flow
Cash flow from continuing investing activities
65.64%-89K
62.71%-742K
92.45%-255K
-63.85%-6.09M
78.65%-459K
67.38%-259K
-302.02%-1.99M
-1,124.28%-3.38M
-211.14%-3.72M
-240.73%-2.15M
Net PPE purchase and sale
65.64%-89K
62.71%-742K
92.45%-255K
-63.85%-6.09M
78.65%-459K
67.38%-259K
-302.02%-1.99M
-1,124.28%-3.38M
-211.14%-3.72M
-240.73%-2.15M
Cash from discontinued investing activities
Investing cash flow
65.64%-89K
62.71%-742K
92.45%-255K
-63.85%-6.09M
78.65%-459K
67.38%-259K
-302.02%-1.99M
-1,124.28%-3.38M
-211.14%-3.72M
-240.73%-2.15M
Financing cash flow
Cash flow from continuing financing activities
-91.96%4.18M
-77.23%2.2M
411,724.36%321.22M
11,580.06%169.83M
23,517.90%108.17M
13,786.36%51.94M
1,856.39%9.65M
-39.53%78K
-49.00%1.45M
-31.33%458K
Net issuance payments of debt
--0
--0
--0
--56.35M
--0
--56.35M
--0
--0
--0
--0
Net common stock issuance
--0
--0
--316.35M
--117.26M
--107.73M
--708K
--8.82M
--0
--0
--0
Proceeds from stock option exercised by employees
6,638.71%4.18M
167.48%2.2M
6,143.59%4.87M
-3.58%1.4M
-3.71%441K
-83.42%62K
66.53%821K
-39.53%78K
-59.28%1.45M
-31.33%458K
Net other financing activities
----
----
----
---5.18M
--0
----
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
-91.96%4.18M
-77.23%2.2M
411,724.36%321.22M
11,580.06%169.83M
23,517.90%108.17M
13,786.36%51.94M
1,856.39%9.65M
-39.53%78K
-49.00%1.45M
-31.33%458K
Net cash flow
Beginning cash position
574.72%461.3M
499.89%484.65M
89.86%197.57M
-37.28%104.06M
-8.47%112.31M
-49.84%68.37M
-45.11%80.79M
-37.28%104.06M
-27.80%165.93M
-32.22%122.71M
Current changes in cash
-173.89%-32.47M
-87.99%-23.35M
1,333.48%287.08M
251.15%93.51M
557.14%85.26M
423.38%43.94M
-14.18%-12.42M
-24.15%-23.27M
3.18%-61.86M
-23.37%-18.65M
End cash Position
281.82%428.83M
574.72%461.3M
499.89%484.65M
89.86%197.57M
89.86%197.57M
-8.47%112.31M
-49.84%68.37M
-45.11%80.79M
-37.28%104.06M
-37.28%104.06M
Free cash flow
-358.62%-36.65M
-15.77%-25.54M
-46.21%-34.14M
-20.54%-76.32M
-19.91%-22.91M
42.77%-7.99M
-94.05%-22.07M
-23.71%-23.35M
5.13%-63.32M
-21.06%-19.11M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -372.83%-36.56M-23.55%-24.8M-69.66%-33.89M-17.84%-70.23M-32.41%-22.45M41.29%-7.73M-84.58%-20.08M-7.38%-19.97M9.07%-59.6M-11.91%-16.96M
Net income from continuing operations -6,972.29%-36.49M-111.67%-43.78M-113.89%-64.85M-13.65%-80.74M-88.01%-29.22M97.87%-516K-10.21%-20.68M-141.73%-30.32M-984.05%-71.04M-303.69%-15.54M
Operating gains losses 66.16%-7.08M367.64%3.03M404.45%33.1M34.96%-9M223.59%6.48M-1,947.35%-20.91M59.21%-1.13M194.34%6.56M82.28%-13.84M66.97%-5.24M
Depreciation and amortization 7.75%959K46.63%956K90.48%920K41.44%2.98M95.11%958K74.85%890K18.12%652K-13.29%483K-12.89%2.11M-13.86%491K
Other non cash items -70.03%621K-54.59%569K60.26%1.97M25.82%6.11M25.55%1.55M69.14%2.07M3.98%1.25M3.54%1.23M4.86%4.85M4.12%1.24M
Change In working capital -119.46%-1.21M168.34%3.13M-420.28%-13.01M-649.37%-7.41M-206.93%-6.55M59.01%6.22M-199.03%-4.58M50.53%-2.5M146.50%1.35M-107.28%-2.14M
-Change in receivables -100.08%-3K40.40%-3.69M-282.59%-367K-2,454.74%-4.85M-70.06%-2.59M447.06%3.72M-326.97%-6.19M109.70%201K97.86%-190K3.79%-1.52M
-Change in inventory 367.92%142K-56.45%27K7.88%-269K54.28%-331K88.81%-48K-17.78%-53K143.66%62K-170.37%-292K-1,377.55%-724K-1,432.14%-429K
-Change in prepaid assets -2,515.24%-7.04M913.07%1.55M117.83%128K-620.89%-3.77M-312.96%-2.93M-155.69%-269K-82.39%153K-986.42%-718K815.84%723K18.76%-710K
-Change in payables and accrued expense 107.45%5.9M671.63%5.44M-669.68%-12.34M32.55%1.36M-172.39%-590K-4.02%2.84M-49.86%705K61.48%-1.6M-81.44%1.02M47.11%815K
-Change in other current assets -19.01%311K-85.52%54K-0.96%413K149.45%1.57M--396K--384K--373K497.14%417K-424.97%-3.18M----
-Change in other current liabilities -63.74%-447K63.58%-193K-49.28%-515K-166.43%-1.81M---665K---273K---530K---345K300.96%2.73M----
-Change in other working capital 39.69%-79K-107.36%-62K63.13%-59K-55.66%427K-178.48%-124K22.02%-131K349.11%842K-112.20%-160K-3.70%963K--158K
Cash from discontinued investing activities
Operating cash flow -372.83%-36.56M-23.55%-24.8M-69.66%-33.89M-17.84%-70.23M-32.41%-22.45M41.29%-7.73M-84.58%-20.08M-7.38%-19.97M9.07%-59.6M-11.91%-16.96M
Investing cash flow
Cash flow from continuing investing activities 65.64%-89K62.71%-742K92.45%-255K-63.85%-6.09M78.65%-459K67.38%-259K-302.02%-1.99M-1,124.28%-3.38M-211.14%-3.72M-240.73%-2.15M
Net PPE purchase and sale 65.64%-89K62.71%-742K92.45%-255K-63.85%-6.09M78.65%-459K67.38%-259K-302.02%-1.99M-1,124.28%-3.38M-211.14%-3.72M-240.73%-2.15M
Cash from discontinued investing activities
Investing cash flow 65.64%-89K62.71%-742K92.45%-255K-63.85%-6.09M78.65%-459K67.38%-259K-302.02%-1.99M-1,124.28%-3.38M-211.14%-3.72M-240.73%-2.15M
Financing cash flow
Cash flow from continuing financing activities -91.96%4.18M-77.23%2.2M411,724.36%321.22M11,580.06%169.83M23,517.90%108.17M13,786.36%51.94M1,856.39%9.65M-39.53%78K-49.00%1.45M-31.33%458K
Net issuance payments of debt --0--0--0--56.35M--0--56.35M--0--0--0--0
Net common stock issuance --0--0--316.35M--117.26M--107.73M--708K--8.82M--0--0--0
Proceeds from stock option exercised by employees 6,638.71%4.18M167.48%2.2M6,143.59%4.87M-3.58%1.4M-3.71%441K-83.42%62K66.53%821K-39.53%78K-59.28%1.45M-31.33%458K
Net other financing activities ---------------5.18M--0--------------------
Cash from discontinued financing activities
Financing cash flow -91.96%4.18M-77.23%2.2M411,724.36%321.22M11,580.06%169.83M23,517.90%108.17M13,786.36%51.94M1,856.39%9.65M-39.53%78K-49.00%1.45M-31.33%458K
Net cash flow
Beginning cash position 574.72%461.3M499.89%484.65M89.86%197.57M-37.28%104.06M-8.47%112.31M-49.84%68.37M-45.11%80.79M-37.28%104.06M-27.80%165.93M-32.22%122.71M
Current changes in cash -173.89%-32.47M-87.99%-23.35M1,333.48%287.08M251.15%93.51M557.14%85.26M423.38%43.94M-14.18%-12.42M-24.15%-23.27M3.18%-61.86M-23.37%-18.65M
End cash Position 281.82%428.83M574.72%461.3M499.89%484.65M89.86%197.57M89.86%197.57M-8.47%112.31M-49.84%68.37M-45.11%80.79M-37.28%104.06M-37.28%104.06M
Free cash flow -358.62%-36.65M-15.77%-25.54M-46.21%-34.14M-20.54%-76.32M-19.91%-22.91M42.77%-7.99M-94.05%-22.07M-23.71%-23.35M5.13%-63.32M-21.06%-19.11M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion with Explanatory Notes--
Heat List
US
Overall
Symbol
Price
% Chg

No Data